Cyril Šálek

Institute of Hematology and Transfusion Medicine

Czech Republic

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Štěpán Hrabovský

Assistant Professor

Masaryk University

CZECH REPUBLIC

View details

Barbora Brodská

Institute of Hematology and Transfusion Medicine

CZECH REPUBLIC

View details

Hana Zizkova

Institute of Hematology and Transfusion Medicine

CZECH REPUBLIC

View details

Blanka Stiburkova

Institute of Rheumatology

CZECH REPUBLIC

View details

Kateřina Kuželová

head of the department

Institute of Hematology and Transfusion Medicine

CZECH REPUBLIC

View details

Adéla Benešová

Institute of Hematology and Transfusion Medicine

CZECH REPUBLIC

View details

Hana Remesova

Institute of Hematology and Transfusion Medicine

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cyril Šálek

Research Interests

Explore related searches

Contact this professor

Articles (10)

MethScore as a new comprehensive DNA methylation-based value refining the prognosis in acute myeloid leukemia.

ABC transporters are predictors of treatment failure in acute myeloid leukaemia

Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome

Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007-2020.

NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia

Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies

Low levels of minimal residual disease after induction chemotherapy for BCR‐ABL1‐negative acute lymphoblastic leukaemia in adults are clinically relevant

A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel

NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia

Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells

Collaborators (7)

Štěpán Hrabovský

Barbora Brodská

Hana Zizkova

Blanka Stiburkova

Kateřina Kuželová

Adéla Benešová

Hana Remesova

Make your next move.